PrecisionMed Inc. Announces Longitudinal Alzheimer's Disease Spinal Fluid Biological SAMPLE Registry
10/9/2007 12:21:00 PM
SAN DIEGO--(BUSINESS WIRE)--PrecisionMed Inc. today announced enrollment of the first subject into THE SAMPLE REGISTRY (Serial Alzheimer’s Disease and MCI Prospective Longitudinal Evaluation). The SAMPLE Registry is a biological sample bank of DNA and serial RNA, CSF, serum and plasma associated with serial cognition testing utilizing PrecisionMed's clinical sample and data procurement and storage capabilities.
comments powered by